Targeting antibody-mediated rejection in the setting of ABO-incompatible infant heart transplantation: Graft accommodation vs. B cell tolerance

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 5, Issue 3, 2005, Pages 223-232

  West, Lori J ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; RITUXIMAB;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; BLOOD GROUP O; CARDIAC GRAFT REJECTION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INFANT; MOUSE; NONHUMAN; ORGAN DONOR; RECIPIENT; XENOTRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES; B-LYMPHOCYTES; BLOOD GROUP INCOMPATIBILITY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; INFANT; INFANT, NEWBORN; KIDNEY TRANSPLANTATION;

EID: 21044459079     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006054064762     Document Type: Article

References (68)

1. Terasaki, P. I. Humoral theory of transplantation. Am. J. Transplant. 2003, 3, 665-673.
2. Starzl, T., Ishikawa, M., Putnam, C., Porter, K., Picache, R., Husberg, B., Halgrimson, C., Schroter, G. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant. Proc. 1974, 6, 129-139.
3. Stock, P., Sutherland, D., Fryd, D., Ascher, N., Payne, W., Simmons, R., Najarian, J. Detrimental effect of ABO mis-matching in renal transplantation. Transplant. Proc. 1987, 19, 711-712.
4. Paul, L., Baldwin, W. M. 3rd. Humoral rejection mechanisms and ABO incompatibility in renal transplantation. Transplant. Proc. 1987, 19, 4463-4467.
5. Michaels, P., Espejo, M., Kobashigawa, J., Alejos, J., Burch, C., Takemoto, S.; Reed, E., Fishbein, M. Humoral rejection in cardiac transplantation: risk factor, hemodynamic consequences and relationship to transplant coronary artery disease. J. Heart Lung Transplant. 2003, 22, 5 8-69.
6. Slapak, M., Naik, R., Lee, H. Renal transplant in a patient with major donor-recipient blood group incompatibility: reversal of acute rejection by the use of modified plasmapheresis. Transplantation 1981, 31, 4-7.
7. Bannett, A., Bensinger, W., Raja, R., Baquero, A., McAlack, R. Immunoadsorption and renal transplant in two patients with major ABO incompatibility. Transplantation 1987, 43, 909-911.
8. Alexandre, G., Squifflet, J., De Bruyere, M., Latinne, D., Reding, R., Gianello, P., Carlier, M., Pirson, Y. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant. Proc. 1987, 19, 4538-4542.
9. Sutherland, D., Fryd, D., So, S., Bentley, F., Ascher, N., Simmons, R., Najarian, J. Long-term effect of splenectomy in renal transplant patients. Reanalysis of a randomized prospective study. Transplantation 1984, 38, 619-624.
10. Takahashi, K., Yagisawa, T., Sonda, K., Kawaguchi, H., Yamaguchi, Y., Toma, H., Agishi, T., Ota, K. ABO-incompatible kidney transplantation in a single-center trial. Transplant. Proc. 1995, 25, 271-273.
11. Tanabe, K., Takahashi, K., Sonda, K., Agishi, T., Kawaguchi, H., Ishikawa, N., Kimata, N., Oshima, S., Goya, N., Nakazawa, H. ABO-incompatible living kidney donor transplantation: results and immunological aspects. Transplant. Proc. 1995, 27, 1020-1023.
12. Osorio, A., Sullivan, E., Alexander, S., Bryan, C., Shield, C., Warady, B. ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB). Pediatr. Transplant. 1998, 2, 26-29.
13. Gugenheim, J., Samuel, D., Reynes, M., Bismuth, H. Liver transplantation across ABO blood group barriers. Lancet 1990, 336, 519-523.
14. Stegall, M. D., Dean, P. G., Gloor, J. M. ABO-incompatible kidney transplantation. Transplantation 2004, 78, 635-640.
15. Warren, D. S., Zachary, A. A., Sonnenday, C. J., King, K. E., Cooper, M., Ratner, L. E., Shirey, R. S., Haas, M., Leffell, M. S., Montgomery, R. A. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am. J. Transplant. 2004, 4, 561-568.
16. Jordan, S. C., Vo, A., Bunnapradist, S., Toyoda, M., Peng, A., Puliyanda, D., Kamil, E., Tyan, D. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 2003, 76, 631-636.
17. Chopek, M. W., Simmons, R. L., Platt, J. L. ABO-incompatible kidney transplantation: initial immunopathologic evaluation. Transplant. Proc. 1987, 19, 4553-4557.
18. Bannett, A. D., McAlack, R. F., Morris, M., Chopek, M. W., Platt, J. L. ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplantation. Transplant. Proc. 1989, 21, 783-785.
19. Lin, S. S., Hanaway, M. J., Gonzalez-Stawinski, G. V., Lau, C. L., Parker, W., Davis, R. D., Byrne, G. W., Diamond, L. E., Logan, J. S., Platt, J. L. The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 2000, 70, 1667-1674.
20. Stevens, R. B., Platt, J. L. The pathogenesis of hyperacute xenograft rejection. Am. J. Kidney Dis. 1992, 20, 414-421.
21. Bach, F. H., Ferran, C., Hechenleitner, P., Mark, W., Koyamada, N., Miyatake, T., Winkler, H., Badrichani, A., Candinas, D., Hancock, W. W. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat. Med. 1997, 3, 196-204.
22. Platt, J. L. C4d and the fate of organ allografts. J. Am. Soc. Nephrol. 2002, 13, 2417-2419.
23. Cooper, D. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J Heart Lung Transplant. 1990, 9, 376-381.
24. Nydegger, U. E., Rieben, R., Carrel, T., Mohacsi, P. Solid organ transplantation across the ABO histo-blood group barrier: a case report. Transplant. Proc. 2004, 36, 1554-1557.
25. Rijkers, G. T., Sanders, E. A., Breukels, M. A., Zegers, B. J. Infant B cell responses to polysaccharide determinants. Vaccine 1998, 16, 1396-1400.
26. Cadoz, M. Potential and limitations of polysaccharide vaccines in infancy. Vaccine 1998, 16, 1391-1395.
27. Gennery, A. R., Cant, A. J., Spickett, G. P., Walshaw, D., Hunter, S., Hasan, A., Hamilton, J. R., Dark, J. Effect of immunosuppression after cardiac transplantation in early childhood on antibody response to polysaccharide antigen. Lancet 1998, 351, 1778-1781.
28. Wilson, C. B. Immunologic basis for increased susceptibility of the neonate to infection. J. Pediatr. 1986, 108, 1-12.
29. Fong, S. W., Qaqundah, B. Y., Taylor, W. F. Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex and maternal isoagglutinins. Transfusion 1974, 14, 551-559.
30. West, L. J., Pollock-BarZiv, S. M., Dipchand, A. I., Lee, K. J., Cardella, C. J., Benson, L. N., Rebeyka, I. M., Coles, J. G. ABO-incompatible heart transplantation in infants. New Engl. J. Med. 2001, 344, 793-800.
31. Rao, J. N., Hasan, A., Hamilton, J. R., Bolton, D., Haynes, S., Smith, J. H., Wallis, J., Kesteven, P., Khattak, K., O'Sullivan, J., Dark, J. H. ABO-incompatible heart transplantation in infants: the Freeman Hospital experience. Transplantation 2004, 77, 1389-1394.
32. Fan, X., Ang, A., Pollock-Barziv, S. M., Dipchand, A. I., Ruiz, P., Wilson, G., Platt, J. L., West, L. J. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. [see comment]. Nat. Med. 2004, 10, 1227-1233.
33. Owen, R. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945, 102, 400.
34. Billingham, R. E., Brent, L., Medawar, P. B. Actively acquired tolerance of foreign cells. Nature 1953, 172, 603-606.
35. McCarthy, S. A., Bach, F. H. The cellular mechanism of maintenance of neonatally induced tolerance to H-2 class 1 antigens. J. Immunol. 1983, 131, 1676-1682.
36. Kappler, J. W., Roehm, N., Marrack, P. T cell tolerance by clonal elimination in the thymus. Cell 1987, 49, 273-280.
37. Streilein, J. W. Neonatal tolerance of H-2 alloantigens. Procuring graft acceptance the "old-fashioned" way. Transplantation 1991, 52, 1-10.
38. Ramsdell, F., Fowlkes, B. J. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 1990, 248, 1342-1348.
39. Dorsch, S., Roser, B. Suppressor cells in transplantation tolerance. Transplantation 1982, 33, 518-524.
40. Zinkernagel, R. M., Hengartner, H. Regulation of the immune response by antigen. Science 2001, 13, 251-253.
41. Holsapple, M. P., West, L. J., Landreth, K. S. Species comparison of anatomical and functional immune system development. Birth Defects Res. Part B Dev. Reprod. Toxicol. 2003, 68, 321-334.
42. West, L. J. Defining critical windows in the development of the human immune system. Hum. Ex. Toxicol. 2002, 21, 499-505.
43. Smalley, C. E., Tucker, E. M. Blood group A antigen site distribution and immunoglobulin binding in relation to red cell age. Br. J. Haematol. 1983, 54, 209-219.
44. Mollison, P. L., Contreras, M., Engelfriet, C. P. Blood transfusion in clinical medicine. 9th ed.; Blackwell Scientific Publ.: Oxford [England], 1993, pp. 1015.
45. Olsson, M. L., Chester, M. A. Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies. Transfusion 2001, 36, 295-313.
46. Ogasawara, K., Yabe, R., Uchikawa, M., Saitou, N., Bannai, M., Nakata, K., Takenaka, M., Fujisawa, K., Ishikawa, Y., Juji, T., Tokunaga, K. Molecular genetic analysis of variant phenotypes of the ABO blood group system. Blood 1996, 88, 2732-2737.
47. Klinman, N. R. The 'clonal selection hypothesis' and current concepts of B cell tolerance. Immunity 1996, 5, 189-195.
48. Nemazee, D. A., Burki, K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989, 337, 562-566.
49. Hartley, S. B., Cooke, M. P., Fulcher, D. A., Harris, A. W., Cory, S., Basten, A., Goodnow, C. C. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1993, 72, 325-335.
50. Rieben, R., Tucci, A., Nydegger, U. E., Zubler, R. H. Self tolerance to human A and B histo-blood group antigens exists at the B cell level and cannot be broken by potent polyclonal B cell activation in vitro. Eur. J. Immunol. 1992, 22, 2713-2717.
51. Hartley, S. B., Crosbie, J., Brink, R., Kantor, A. B., Basten, A., Goodnow, C. C. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991, 353, 765-769.
52. Lang, J., Nemazee, D. B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition. Eur. J. Immunol. 2000, 30, 689-696.
53. Luo, W., Fine, J., Garg, M., Kaplan, A. M., Bondada, S. Interleukin-10 enhances immune responses to pneumococcal polysaccharides and sheep erythrocytes in young and aged mice. Cell Immunol. 1999, 195, 1-9.
54. Splawski, J. B., Lipsky, P. E. Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes. J. Clin. Invest. 1991, 88, 967-977.
55. Goodnow, C. C. Pathways for self-tolerance and the treatment of autoimmune diseases. Lancet 2001, 357, 2115-2121.
56. Goodnow, C. C. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 1996, 93, 2264-2271.
57. Monroe, J. G. Molecular mechanisms regulating B cell responsiveness and tolerance. Transplantation 2005, 79, S12-13.
58. Jankovic, M., Casellas, R., Yannoutsos, N., Wardemann, H., Nussenzweig, M. C. RAGs and regulation of autoantibodies. Annu. Rev. Immunol. 2004, 22, 485-501.
59. Tiegs, S. L., Russell, D. M., Nemazee, D. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 1993, 177, (4), 1009-1020.
60. Gay, D., Saunders, T., Camper, S., Weigert, M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 1993, 177, 999-1008.
61. Yu, W., Misulovin, Z., Suh, H., Hardy, R. R., Jankovic, M., Yannoutsos, N., Nussenzweig, M. C. Coordinate regulation of RAG1 and RAG2 by cell type-specific DNA elements 5′ of RAG2. Science 1999, 285, 1080-1084.
62. Monroe, R. J., Seidl, K. J., Gaertner, F., Han, S., Chen, F., Sekiguchi, J., Wang, J., Ferrini, R., Davidson, L., Kelsoc, G., Alt, F. W. RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity 1999, 11, 201-212.
63. Sandel, P. C., Monroe, J. G. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity 1999, 10, 289-299.
64. Kouskoff, V., Nemazee, D. Role of receptor editing and revision in shaping the B and T lymphocyte repertoire. Life Sci. 2001, 69, 1105-1113.
65. Yu, W., Nagaoka, H., Jankovic, M., Misulovin, Z., Suh, H., Rolink, A., Melchers, F., Meffre, E., Nussenzweig, M. C. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization. [see comment]. Nature 1999, 400, 682-687.
66. Koestner, S. C., Kappeler, A., Schaffner, T., Carrel, T. P., Nydegger, U. E., Mohacsi, P. Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation. Lancet 2004, 363, 1523-1525.
67. O'Connell, J. B., Renlund, D. G., Bristow, M. R., Hammond, E. H. Detection of allograft endothelial cells of recipient origin following ABO-compatible, nonidentical cardiac transplantation. Transplantation 1991, 51, 438-442.
68. Cooper, M. D., Lusher, J. Immunologic tolerance of ABO incompatible erythrocytes in human neonates. J. Pediatr. 1964, 65, 831-838.